June 7, 2018 / 8:28 PM / in 4 months

BRIEF-FDA Approves Genentech’S Rituxan For Pemphigus Vulgaris

June 7 (Reuters) - Roche Holding AG:

* FDA APPROVES GENENTECH’S RITUXAN (RITUXIMAB) FOR PEMPHIGUS VULGARIS

* GENENTECH- RITUXAN IS NOW FDA-APPROVED TO TREAT FOUR AUTOIMMUNE DISEASES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below